Evidence map›Paper›PMID 26768563›Full record

ArticleClinical trials (London, England)2016

Evaluating interventions for Ebola: The need for randomized trials.

Thomas R Fleming, Susan S Ellenberg

Abstract read
In one paragraph

Article in Clinical trials (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Monitoring clinical trials in infectious diseases.Journal of allergy and infectious diseases · 2021
    Article
  4. Resist the Temptation of Response-Adaptive Randomization.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  5. Review
  6. Designing & Conducting Trials To Reliably Evaluate HIV Prevention Interventions.Statistical communications in infectious diseases · 2019
    Article
  7. Article
  8. Rigorous Clinical Trial Design in Public Health Emergencies Is Essential.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  9. Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Review
  10. Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thomas R FlemingDepartment of Biostatistics, University of Washington, Seattle, WA, USA tfleming@uw.edu.
Susan S EllenbergDepartment of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Funding

STATISTICAL ISSUES IN AIDS RESEARCHR37AI029168 · NIAID · UNIVERSITY OF WASHINGTON · PI JAMES P HUGHES · 1999 to 2026
$9.8M
STATISTICAL ISSUES IN AIDS RESEARCHR01AI029168 · NIAID · UNIVERSITY OF WASHINGTON · PI HUGHES, JAMES P · 1989 to 2018
$5.3M
NIAID NIH HHS R37 AI029168NIAID NIH HHS R37 AI 29168
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Randomized Controlled Trials as TopicResearch DesignDisease OutbreaksGuineaHemorrhagic Fever, EbolaHumansLiberiaSierra Leone

Identifiers

PMID26768563
PMCPMC4767552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.